"Bienvenue à la clinique TIVOLI DUCOS Située au coeur de Bordeaux notre clinique fait partie de l’histoire de cette ville depuis bientôt 100 ans. Au cours du temps elle s’est modernisée pour offrir aux patients un pôle technique de grande qualité, tout en conservant sa convivialité. Dans un cadre idéalement adapté, notre communauté médicale exerce à la pointe des connaissances médicales actuelles. Toutes les équipes de la clinique Tivoli-Ducos s’engagent chaque jour avec passion pour vous soigner et vous aider à guérir avec dignité et humanité. Nous vous remercions de la confiance que vous nous témoignez et vous souhaitons un prompt et complet rétablissement. Bruno Alfandari, Président du Directoire"

During the past decade, Clinique Tivoli conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 4 clinical trials were completed, i.e. on average, 13.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 4 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Tivoli" #1 sponsor was "ARCAGY/ GINECO GROUP" with 12 trials, followed by "UNICANCER" with 7 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 6 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 6 trials sponsored and "Institut Bergonié" with 6 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Tivoli" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "UNICANCER" with 3 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Tivoli" are "Ovarian Cancer" (8 trials), "Breast Cancer" (5 trials), "Colorectal Cancer" (4 trials), "Metastatic Breast Cancer" (4 trials) and "Pancreatic Cancer" (4 trials). Many other conditions were trialed in "Clinique Tivoli" in a lesser frequency.

Most popular intervention types in "Clinique Tivoli" are "Drug" (41 trials), "Procedure" (11 trials), "Radiation" (10 trials), "Biological" (5 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (6 trials), "Bevacizumab" (5 trials), "fluorouracil" (5 trials), "Capecitabine" (4 trials) and "adjuvant therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Tivoli" are 30 trials for "All" genders, 27 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Tivoli". undefined are not yet recruiting, 14 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Clinique Tivoli, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Tivoli, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".

Clinique Tivoli has several departments that took part in Clinical trials: "Clinique Tivoli; Sce Radiotherapie" - 12 trials